ANTIBODIES AGAINST SARS-COV-2 - FRED HUTCHINSON CANCER CENTER

Title:

ANTIBODIES AGAINST SARS-COV-2

Document Type and Number:

WIPO Patent Application WO/2024/020577

Kind Code:

A3

Abstract:

Provided herein are monoclonal antibodies or antigen-binding fragments thereof that bind to the viral envelope spike protein of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Also provided herein are using such molecules for detecting and treating SARS-CoV-2.

Inventors:

OVERBAUGH JULIE (US)
GUENTHOER JAMIE (US)

Application Number:

PCT/US2023/070768

Publication Date:

February 29, 2024

Filing Date:

July 21, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

FRED HUTCHINSON CANCER CENTER (US)

International Classes:

C07K16/10; A61K39/215; A61K39/42; A61P31/14

Domestic Patent References:

WO2021222128A1	2021-11-04
WO2018148566A1	2018-08-16
WO2022140845A1	2022-07-07

Foreign References:

US20210332110A1

2021-10-28

Attorney, Agent or Firm:

BAILEY, Mark A. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: FLEXIBLE WIRELESS LABELS AS PRINTABLE REELED-MEDIA FOR TRACKING ITEMS ACROSS WIDE AND LOCAL AREA NET...

Next Patent: SYSTEMS AND METHODS FOR ENGINEERING CELL-TYPE SPECIFICITY IN MRNA